Literature DB >> 17786318

Altered expression of DNA-dependent protein kinase catalytic subunit (DNA-PKcs) during gastric carcinogenesis and its clinical implications on gastric cancer.

Hye Seung Lee1, Gheeyoung Choe, Kyoung Un Park, Do Joong Park, Han-Kwang Yang, Byung Lan Lee, Woo Ho Kim.   

Abstract

DNA-dependent protein kinase catalytic subunit (DNA-PKcs) is a 465-kDa catalytic subunit of DNA-PK, a DNA repair apparatus. DNA-PKcs has been reported to be a tumor suppressor, but details of its expression in human cancer are controversial. To determine the protein expression and clinical implications of DNA-PKcs in gastric carcinogenesis and cancer progression, we evaluated its expression status by immunohistochemistry in 122 non-neoplastic gastric mucosa samples, and in 115 gastric adenomas and 564 consecutive gastric cancers. In addition, we evaluated the clinicopathologic characteristics of gastric cancers showing altered DNA-PKcs expression, and performed microsatellite instability (MSI) analysis at BAT-26 and frameshift mutation analysis of DNA-PKcs. DNA-PKcs expression was negative in foveolar epithelium of normal gastric mucosal tissues, but was positive in most Helicobacter pylori-associated gastritis, intestinal metaplasia and gastric adenoma tissues. In gastric cancers, negative expression of DNA-PKcs was found in 114 of the 564 (20.2%) cancers and was significantly associated with intratumoral neutrophils, MSI-high (H) phenotype, tumor progression, and poor patient survival (p<0.05). Frameshift mutations of (A)10 mononucleotide repeats in DNA-PKcs were found in 24.3% of MSI-H gastric cancers and these were associated with negative expression of DNA-PKcs. Although patients with MSI-H gastric cancers were found to have a lower risk of lymph node metastasis, gastric cancers harboring the (A)10 mutation of DNA-PKcs were found to have a higher risk of lymph node metastasis. In conclusion, the expression of DNA-PKcs was found to be altered during gastric carcinogenesis and negative DNA-PKcs expression was associated with gastric cancer progression. The (A)10 frameshift mutation of DNA-PKcs in gastric cancers was a target of defective mismatch repair, and was associated with lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17786318

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  23 in total

Review 1.  Genotypic characteristics of resistant tumors to pre-operative ionizing radiation in rectal cancer.

Authors:  Zeeshan Ramzan; Ammar B Nassri; Sergio Huerta
Journal:  World J Gastrointest Oncol       Date:  2014-07-15

2.  Lack of the catalytic subunit of DNA-dependent protein kinase (DNA-PKcs) is accompanied by increased CK2α' levels.

Authors:  Birgitte B Olsen; Ulrike Fischer; Tine L Rasmussen; Matthias Montenarh; Eckart Meese; Gerhard Fritz; Olaf-Georg Issinger
Journal:  Mol Cell Biochem       Date:  2011-07-13       Impact factor: 3.396

Review 3.  Epigenetic regulation of DNA repair machinery in Helicobacter pylori-induced gastric carcinogenesis.

Authors:  Juliana Carvalho Santos; Marcelo Lima Ribeiro
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

4.  Differential role of DNA-PKcs phosphorylations and kinase activity in radiosensitivity and chromosomal instability.

Authors:  Hatsumi Nagasawa; John B Little; Yu-Fen Lin; Sairei So; Akihiro Kurimasa; Yuanlin Peng; John R Brogan; David J Chen; Joel S Bedford; Benjamin P C Chen
Journal:  Radiat Res       Date:  2010-11-17       Impact factor: 2.841

5.  Repair of radiation damage of U2OS osteosarcoma cells is related to DNA-dependent protein kinase catalytic subunit (DNA-PKcs) activity.

Authors:  Xianye Tang; Feng Yuan; Kaijin Guo
Journal:  Mol Cell Biochem       Date:  2014-01-05       Impact factor: 3.396

6.  DNA-PKcs deficiency leads to persistence of oxidatively induced clustered DNA lesions in human tumor cells.

Authors:  Prakash Peddi; Charles W Loftin; Jennifer S Dickey; Jessica M Hair; Kara J Burns; Khaled Aziz; Dave C Francisco; Mihalis I Panayiotidis; Olga A Sedelnikova; William M Bonner; Thomas A Winters; Alexandros G Georgakilas
Journal:  Free Radic Biol Med       Date:  2010-03-01       Impact factor: 7.376

7.  Radiosensitization and growth inhibition of cancer cells mediated by an scFv antibody gene against DNA-PKcs in vitro and in vivo.

Authors:  Li Du; Li-Jun Zhou; Xiu-Jie Pan; Yu-Xiao Wang; Qin-Zhi Xu; Zhi-Hua Yang; Yu Wang; Xiao-Dan Liu; Mao-Xiang Zhu; Ping-Kun Zhou
Journal:  Radiat Oncol       Date:  2010-08-12       Impact factor: 3.481

8.  Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatment.

Authors:  Feng-Ming Hsu; Shichuan Zhang; Benjamin P C Chen
Journal:  Transl Cancer Res       Date:  2012-05-22       Impact factor: 1.241

9.  Abnormal DNA-PKcs and Ku 70/80 expression may promote malignant pathological processes in gastric carcinoma.

Authors:  Wei Li; Chuan Xie; Zhen Yang; Jiang Chen; Nong-Hua Lu
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

10.  Identification of genes with a correlation between copy number and expression in gastric cancer.

Authors:  Lei Cheng; Ping Wang; Sheng Yang; Yanqing Yang; Qing Zhang; Wen Zhang; Huasheng Xiao; Hengjun Gao; Qinghua Zhang
Journal:  BMC Med Genomics       Date:  2012-05-04       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.